Kardium has developed an advanced system for the treatment of atrial fibrillation, offering a complete solution that includes single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation using a single catheter.

Kardium

Kardium Inc. | 10,855 followers on LinkedIn. Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation.                                                                                                                                                                                              



 .

Practical vision

David Kauffman

Award-winning senior technical writer

Jennifer Paton Smith

Jeff Brewster

Vice President, Product Management - Kardium Inc.

Stefan Avall

Kardium Inc.

Thank you Dr. Devi G Nair, MD, FACC, FHRS for sharing this exciting case with our Globe System.

Always fun at the Kardium summer BBQ. Great to hang out with our team and their families.

Thank you TSX Trust for the congratulations at the Toronto Stock Exchange on our $104M financing!

Thanks Christopher Woods, MD PhD for sharing your positive thoughts on our clinical data. We are also looking forward to sharing the exciting results of the PULSAR study.

Here is our CEO Kevin sharing details about our device. We are on a path to delivering the best treatment for afib! Come and join us!

Nasdaq congratulates Kardium Inc. on closing our recent financing round. That's pretty cool!

Congratulations to Kardium Inc. ! On May 31, they successfully raised USD $104 million in a financing round led by Fidelity Management And Research Company , alongside T. Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., and new investor Durable Capital Partners LP . This significant investment will accelerate Kardium's initiatives, including completing the PULSAR clinical study, securing regulatory approvals, expanding manufacturing capabilities, and establishing a strong clinical and commercial team for the Globe System launch. Our team was honored to support Kardium Inc. throughout this transformative journey. Learn more: https://bit.ly/3KOmT6i #ClientSuccess #MedicalInnovation #AtrialFibrillation #HealthcareInnovation #LegalExcellence #Fasken #KardiumInc

Fasken Emerging Tech

Exciting news at Kardium Inc. ! We've secured funding that will allow us to pursue regulatory approval and commercial launch of the Globe System! We look forward to bringing the best treatment for atrial fibrillation to the world! Thanks to the teams at Fidelity Investments , T. Rowe Price , Durable Capital Partners LP for your investment and supporting our mission at Kardium Inc. https://lnkd.in/g53gKKge

Domain Not Resolving

DNSSEC

IPv6

Person Schema

U.S. Server Location

ASP.NET

IIS 10

Microsoft

Apache 2.4

Business Management

Kevin Chaplin

Chief Financial Officer

Koert VandenEnden

Human Resources

Candice Hollingsworth (ACC)

Engineering

Daniel Weinkam

Vice President, Regulatory Affairs & Quality Assurance

Ricardo Romero

Director of Intellectual Property

Aldo Salvestro

Operations

Alex Wilson

Director, Research

Daniel Reinders

Director, Quality Engineering

Naghmeh Ghafari

Director of Product Management

Saar Moisa

John Yeung

John Webb

Hans Kottkamp

James Abel

Doug Goertzen

President and COO

Sam Lichtenstein

Co-Founder & Advisor

Dan Gelbart

Canada Companies With Fewer Than 1000 Employees (Top 10K)

Health Diagnostics Companies With More Than $10M in Revenue

British Columbia Companies With Fewer Than 1000 Employees (Top 10K)

British Columbia Companies With Less Than $500M in Revenue (Top 10K)

Kardium is a technology pioneer working to advance medical device technology in the diagnosis and treatment of atrial fibrillation.

Kardium was founded in 2007 and has built an outstanding team with a track record of excellence in medicine, business, and engineering.  We have hired the best engineers, medical researchers and production staff and have been working with a team of top medical advisors to develop the Globe mapping and ablation system.  The Globe system has been entirely developed by the team at Kardium and provides a complete system to assist in the diagnosis and treatment of atrial fibrillation.

Kardium is based in Vancouver, Canada, and has consistently ranked as one of the top companies to work for in British Columbia.

Fidelity

Private Equity Round - Kardium

T. Rowe Price

Series D - Kardium

Venture Round - Kardium

Computer and Software Products and Electrical and Scientific Products

Richmond

British Columbia

Canada

North America

Kardium raises $104M for pulsed field ablation system

Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment

Kardium secures $143 million CAD to help bring irregular heartbeat treatment to market

Kardium: Atrial Fibrillation Treatment Company Raises $104 Million

Kardium Touts Enhanced Clinical Capabilities of the Globe System

Kardium: $104 Million Raised To Help Treat Atrial Fibrillation

Kardium nets atrial fibrillation CE mark for its spherical heart ablation catheter

A system for treating atrial fibrillation that combines pulmonary vein isolation, high-definition mapping, and atrial ablation in a single catheter.

Offers rapid pulmonary vein isolation, high-resolution mapping, and atrial ablation with a single catheter equipped with 122 electrodes.

A catheter with a 30 mm spherical array and 122 electrodes for creating high-definition anatomical and electrical maps and delivering pulsed electric field energy for atrial fibrillation treatment.

An international, multi-center clinical trial to evaluate the safety and effectiveness of the Globe System for atrial fibrillation treatment.

Thailand

Asia

United Kingdom

Europe

HTML5

Google Maps API

Google Analytics

Amazon EC2

jQuery

Wordpress

Modernizr

Google Compute Engine

Vimeo

Apache Server

Kardium owns Kardium Burnaby

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 2:29 AM	b8abc14f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 2:29 AM	ba3c2fd1
crunchbase trigger	general	Nov 19, 2024 2:29 AM	961b5637
crunchbase profile	general	Nov 19, 2024 7:56 PM	e5943944
li profile	general	Nov 19, 2024 2:29 AM	0951c1e0
translate crunchbase fundingrounds	general	Nov 19, 2024 9:05 PM	88a2fb1b
peers	general	Nov 19, 2024 2:29 AM	4b429200
news basic	general	Nov 19, 2024 2:29 AM	4d95e024
bundesanzeiger	filings
financials download nd	financials
private financials	financials

KARD

COM:KARDIUM

Kardium